U lcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) involving the colonic mucosa, always involving the rectum, and often extending proximally in a continuous way. Approximately one third of patients diagnosed with ulcerative colitis involving the colon proximal to the splenic flexure will require surgery within 15 years of diagnosis in the form of subtotal colectomy and ileostomy, 1 either because of medically refractory disease or the development of dysplasia or invasive cancer. Patients may keep their ileostomy permanently with the diverted rectum (DR) left in place, or with a later completion proctectomy. Alternatively, restoration of bowel continuity can be obtained by means of either an ileorectal anastomosis (IRA) or an ileal pouch-anal anastomosis (IPAA). 2 The IPAA is the gold standard and thus is preferred in most parts of the world, however, IPAA and IRA are used equally in Sweden. 3 Cancer development is a well-known risk associated with long-standing extensive ulcerative colitis in noncolectomized patients. 4 Less is known about the risk for rectal cancer in colectomized patients, in particular for patients with ileostomy and the diverted rectum in place. There are some reports on the risk of developing rectal cancer in IPAA [5] [6] [7] and IRA, 6, 8, 9 but the risk estimates in these studies are not population-based because they are from centers of excellence and as such more severely ill patients were included.
This study aimed to assess the risk of developing rectal cancer in the diverted rectal stump or after reconstruction with IRA or IPAA in colectomized UC patients and to compare this risk with that for the general population. A second aim was to identify other risk factors for the development of rectal cancer (RC).
Method

Setting
A unique personal identity number is assigned to all permanent residents in Sweden. Through linkage of the Swedish Patient Register and the Swedish Cancer Register, this identity number enables us to identify all subsequent diagnoses made for each patient for various diseases (including cancer and severe dysplasia), surgeries performed, causes of death, and migration from Sweden. However, low-grade dysplasia is not reported in the registries.
Cohort
A cohort was identified from the Swedish Patient Register including all patients with a diagnosis of IBD in Sweden between January 1, 1964, and December 31, 2010. For this study we selected all patients with a diagnosis of UC (International Classification of Diseases [ICD]-7 codes: 572.20, 572.21, and 578.03; ICD-8 codes: 563.10 and 569.02; ICD-9 code: 556*; and ICD-10 code: K51*). The type of IBD diagnosis may change over time-the last registered IBD type was used in this study as the true diagnosis for patients with varying registrations. The date of the first registered IBD diagnosis was considered as the date of onset of the disease. A concomitant diagnosis of primary sclerosing cholangitis (PSC) also was identified (ICD-7 code: K585.29; ICD-8 code: 575.05; ICD-9 code: 576B; and ICD-10 code: K83.0).
From this cohort of UC patients, we identified all patients who had undergone surgery with a subtotal colectomy (operation codes: 4651, JFH10, JFH11, or JFH96). We also identified patients who had multiple partial colonic resections eventually adding up to a subtotal colectomy. The final surgery in this chain of surgeries was regarded as the date of colectomy. This defines the study subcohort of UC patients with colectomy and retained and DR. We also identified the subcohorts of patients in whom the colectomy was followed by restoration of intestinal continuity through an IRA (operation code: 4650, JFH00, JFH01, JFC40, JFC41, JFG26, or JFG29) or an IPAA (operation code: 4654, 4823, JFH30, JFH33, JGB50, JGB60, or JGB61), in both cases either as a primary (at time of colectomy) or secondary reconstruction (after a time period with defunctioned rectum).
Primary Outcome
The primary aim was to estimate the risk of developing rectal cancer in the 3 subcohorts of UC patients during follow-up evaluation after subtotal colectomy with retained and diverted rectum or after reconstruction with IRA or IPAA. This risk was compared with that in the general Swedish population through estimating the Standardized Incidence Ratio (SIR).
Statistical Analysis
Follow-up evaluation started on the day of discharge after the subtotal colectomy or after the construction of an IRA or IPAA, respectively. We found that some patients received their rectal cancer diagnosis only after several weeks had passed after a colectomy or proctectomy, probably because of delays in the pathology service and registration procedure. A rectal cancer diagnosis registered within 30 days after the date of admission for colectomy or reconstructive surgery with an IRA or IPAA therefore was assigned to the period that preceded the colectomy, IRA, or IPAA, respectively. For patients with a DR the follow-up period ended on the date of rectal cancer, reconstructive surgery with an IRA or IPAA, proctectomy, death, emigration, or December 31, 2010, whichever came first. For patients with an IRA the follow-up period ended on the date of rectal cancer, reconstructive surgery with an IPAA, proctectomy, death, emigration, or December 31, 2010, whichever came first. For patients with an IPAA the follow-up period ended on the date of rectal cancer, pouchectomy, death, emigration, or December 31, 2010, whichever came first.
The risk for cancer was assessed by survival analytic technique with Kaplan-Meier curves and the log-rank test, as well as univariable and multivariable Cox regression analysis. SIRs were estimated using age-, sex-, and period-specific incidence rates for the Swedish population obtained from the web-based statistical service of the Swedish National Board of Health and Welfare. 10 Differences in proportions were analyzed with the chi-square and the Fisher exact test as appropriate.
The analyses were performed with Stata 13 (StataCorp, College Station, TX). Statistical tests were 2-sided, and statistical significance was set at the 0.05 level. The study was approved by the Linköping Regional Ethics Review Board (Dnr 2011/419-31).
Results
During the study period from 1964 to 2010, a total of 63,795 patients were diagnosed with UC with a male to female ratio of 1.12:1. A total of 7889 (12%) patients underwent colectomy for complicated or severe medically refractory disease or severe dysplasia/cancer after a mean duration of 4.3 years (SD, 6.2 y) from IBD diagnosis ( Figure 1 ). The rectum was removed along with the colon (proctocolectomy) in 1908 of these patients. Another 95 patients were excluded because of inconsistent or erroneous registrations, leaving 5886 patients with subtotal colectomy for analysis. A reconstruction was performed with an IRA in 1112 patients and with an IPAA in 1796 patients, either at the time of colectomy or shortly thereafter. Seventy-six patients underwent a reconstruction twice, with an IRA as a first step later followed by an IPAA. A total of 4358 patients lived with a diverted rectum until the reconstruction, until they had a completion proctectomy, or for a time after either. Rectal cancer occurred in 46 (0.8%) of the 5886 subtotally colectomized patients ( Table 1) . Time from IBD diagnosis was not a risk factor for RC in the multivariable analysis, despite being a risk factor in the univariable analysis ( Table 2 ).
Ileorectal Anastomosis
An IRA was constructed in 1112 patients. RC developed in 20 of these patients (1.8%) after a mean follow-up period of 8.6 years (SD, 9.1 y) (range, 0.0-45.1 y) ( Table 1) . Compared with the Swedish background population patients with an IRA had an almost 9-fold higher overall risk of rectal cancer (SIR, 8.7; 95% confidence interval [CI], 5.6-13.4) (Supplementary Table 1 ). The cumulative risk of developing RC was 1.6% (95% CI, 0.7-3.3) at 10 years and 5.6% (95% CI, 3.3-9.3) at 20 years follow-up evaluation after an IRA (Table 1 and Figure 2 ). Time from IBD diagnosis was not a risk factor of developing RC with an IRA in the multivariable analysis, despite a strong trend in univariable analysis (Table 3) .
Analysis with univariable Cox regression identified PSC as a risk factor for RC after reconstruction with an IRA (Table 3) . A trend was noted for the duration of the IBD diagnosis at IRA as a risk factor as well. Only PSC remained as an independent risk factor in multivariable analyses, after adjustment for covariates. Patients going through ileorectal anastomosis, proctocolectomy, ileal pouch-anal anastomosis, or completion proctectomy at a later stage are included as patients with defunctioned rectum until proctectomy or reconstruction took place.
Ileal Pouch-Anal Anastomosis
The 1796 patients undergoing reconstruction with an IPAA were followed up for a mean of 12.2 years (SD, 6.3 y), and only 1 patient (0.06%) developed RC, giving a SIR of 0.4 (95% CI, 0.0-2.5) when compared with the general population. The patient was 25 years old at the time of the cancer diagnosis and had no previous history of severe dysplasia, cancer, or PSC. He died 1 year later of advanced rectal cancer.
Intact Diverted Rectum
A total of 4358 patients were followed up with an intact and diverted rectum. RC developed in 25 patients (0.6%) after a mean follow-up period of 5.7 years (SD, 7.8 y) after colectomy ( Table 1) , 2 of them already during the first year after colectomy (Supplementary Table 2 ). Compared with the Swedish background population, UC patients with an intact and diverted rectum after colectomy had an almost 4-fold increased risk of rectal cancer (SIR, 3.8; 95% CI, 2.6-5.7). The mean duration of IBD before colectomy was 3.6 years (SD, 5.6 y) within this group of patients.
The cumulative risk of developing RC in the DR patients was 0.5% (95% CI, 0.3-1.1) at 10 years and 2.2% (95% CI, 1.4-3.6) at 20 years after colectomy (Table 1 and Figure 3 ).
For patients with a deviated rectum, a history of severe dysplasia or colon cancer and duration of UC at colectomy were associated with the RC risk in univariable Cox regression (Table 2) . Only a history of severe dysplasia or colon cancer remained statistically significant in multivariable analysis.
Discussion
This population-based cohort study investigated the risk of developing rectal cancer in 5886 patients after subtotal colectomy as a result of ulcerative colitis. The absolute and relative risk of rectal cancer after reconstruction with an IPAA was very low compared with the general Swedish population. By contrast, patients with a deviated rectum or IRA had an increased relative risk with a SIR of 3.8 and 8.7, respectively. However, the absolute cancer risk after a DR and IRA still was moderate, with a cumulative risk after 20 years of follow-up evaluation of 2.2% and 5.6%, respectively. No significant change in the risk of developing rectal cancer was observed during the decades that the study spanned. This study investigated the risk of developing rectal cancer in a diverted rectum after a subtotal colectomy owing to UC.
IPAA is the preferred reconstruction in many countries. In terms of rectal cancer, it is the safest option, with only 1 patient developing cancer of the 1796. In addition, there are few previous case reports of an adenocarcinoma after an IPAA with a UC diagnosis. 5, 11 In older patients and in patients unsuitable for an IPAA (eg, perineal disease or poor sphincter function), reconstruction with an IRA can be performed quite safely as long as patients are aware of the necessity of topical therapy (eg, high-dose mesalamine) and annual follow-up evaluations with flexible endoscopy and multiple biopsies. 6, [11] [12] [13] It also may be advantageous for patients who are relatively young to postpone an IPAA and pelvic surgery until later in life to avoid the associated impairment of fecundity and sex life. 12, [14] [15] [16] [17] [18] It has been suggested that laparoscopic construction of an IPAA may have fewer such side effects, but further studies of this possibility are required. 
19,20
Other Risk Factors for Cancer
Patients with an IRA and PSC were found to have an almost 6-fold increased risk for RC compared with other UC patients, in accordance with previous reports. 21 It has been suggested that bile composition and/or the fecal content in PSC patients may increase the cancer risk, 22 but the increased risk was observed only in PSC patients with concomitant IBD. 23 Interestingly, PSC was not found to increase the risk for RC in a DR in the present study. This raises the question about the role of the fecal stream for cancer development in PSC patients. Further studies in this particular area are warranted.
Overall, patients with severe dysplasia or previous colonic cancer were found to have a higher risk for later being diagnosed with RC. This is in keeping with previous studies from our group and others 6, 9, 13 and is a good reason for offering these patients counseling to consider proctectomy with or without IPAA.
Limitations
As a first limitation, a previous study from Sweden found the anastomoses after IRA to be 26 cm above the anal verge on average. 24 As a result, some of the assumed IRAs are in fact ileosigmoidal anastomoses and some sigmoidal cancers may have been misclassified as rectal cancers. The same applies to patients with a diverted rectum because more than 15 cm of the distal bowel commonly is left at colectomy. Consequently, the relative risk of rectal cancer in an IRA and DR compared with the general population may be overestimated. Second, there is a possibility that asymptomatic cancers were present at colectomy and remained undetected until months or even years after the colectomy. However, there was only a small risk of rectal cancer development during the first 10 years after an IRA (Figure 2) , and the majority of patients with the rectum left in situ were diagnosed with RC more than 5 years after the subtotal colectomy ( Figure 3 ). This is in line with previous reports from our own and other centers. 6, 9, 25, 26 A third limitation inherent in the study design was that retrieving data from registries can have a few weaknesses, including lack of information regarding indication for surgery, smoking status, and hereditary differences for instance. The large sample size compensates for these possible weaknesses in many ways. Use of a nationwide registry also eliminates the risk of selection bias that occurs in cohort studies from expert centers with proportionally more severely ill patients.
The Swedish Patient Registry was found in a recent study 27 to have a positive predictive value between 85% and 95% regarding diagnoses and procedures. In addition, the large sample size and the long follow-up period make the register suitable for large-scale populationbased research. Linkage to the Swedish Cancer Registry, to which both clinicians and pathologists must report, increases the validity of the Patient Registry. 28 
Conclusions
An IPAA is the safest surgical option for colectomized UC patients concerning rectal cancer development. Despite an increased relative risk for RC in patients with an IRA or the rectum left in situ, the actual risk associated with IRA still is moderate, in particular during the first 10 years. Therefore, both IRA and DR 
